The University of Chicago Header Logo

Connection

Richard A. Larson to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Cost-Benefit Analysis.
Richard A. Larson
Connection Strength
0.027
Cost-Benefit Analysis
  1. Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. J Natl Cancer Inst. 2016 Jul; 108(7).
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.